To the full analysis
Shandong Hualu-Hengsheng Chemical stock: growth
600426.SSShandong Hualu-Hengsheng Chemical reported $4.64B in revenue for fiscal 2025, down 9.5% on the prior year, up 18.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
16.1%
per year from 2006 to 2025, per share 12.1%
Earnings (Annual rate)
15%
per year from 2006 to 2025, per share 11.1%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 18.7% | 13.6% | 16.1% |
| Revenue per share | 18.6% | 13.5% | 12.1% |
| Earnings | 13.0% | 13.9% | 15.0% |
| Earnings per share | 12.9% | 13.8% | 11.1% |
| Free cash flow | 7.6% | −11.2% | no data |
| Free cash flow per share | 7.5% | −11.3% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $270.98M | $35.04M | −$77.98M |
| 2007 | $430.07M | $48.03M | $7.26M |
| 2008 | $516.43M | $56.52M | −$67.2M |
| 2009 | $599.54M | $63.75M | −$13.96M |
| 2010 | $710.49M | $38.11M | −$91.28M |
| 2011 | $779.13M | $53.19M | −$267.8M |
| 2012 | $1.05B | $67.72M | −$93.84M |
| 2013 | $1.27B | $73.41M | $20.06M |
| 2014 | $1.46B | $120.64M | $111.54M |
| 2015 | $1.3B | $135.66M | $268.91M |
| 2016 | $1.15B | $131.29M | −$40.01M |
| 2017 | $1.56B | $183.26M | −$67.38M |
| 2018 | $2.15B | $452.84M | $397.91M |
| 2019 | $2.13B | $367.87M | $282M |
| 2020 | $1.97B | $269.69M | $56.84M |
| 2021 | $4.01B | $1.09B | $184.97M |
| 2022 | $4.54B | $943.18M | $4.4M |
| 2023 | $4.09B | $536.26M | −$595.39M |
| 2024 | $5.13B | $585.25M | −$16.89M |
| 2025 | $4.64B | $497.21M | $82.11M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 8 May 2026)
- Valuation signal Undervalued since 11 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.